243 related articles for article (PubMed ID: 16534509)
1. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
[TBL] [Abstract][Full Text] [Related]
2. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
[TBL] [Abstract][Full Text] [Related]
5. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
[TBL] [Abstract][Full Text] [Related]
6. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
[TBL] [Abstract][Full Text] [Related]
7. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Dattoli M; Wallner K; True L; Cash J; Sorace R
Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
[TBL] [Abstract][Full Text] [Related]
8. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
9. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
11. Postoperative inguinal hernia after radical prostatectomy for prostate cancer.
Abe T; Shinohara N; Harabayashi T; Sazawa A; Suzuki S; Kawarada Y; Nonomura K
Urology; 2007 Feb; 69(2):326-9. PubMed ID: 17275071
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
[TBL] [Abstract][Full Text] [Related]
13. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
15. Study of prostate cancer pathologic features in Chinese populations.
Chuang AY; Chang SJ; Horng CF; Tsou MH
Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934
[TBL] [Abstract][Full Text] [Related]
16. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy.
Li Y; Mizutani Y; Shiraishi T; Okihara K; Ukimura O; Kawauchi A; Nonomura N; Fukushima M; Sakai T; Miki T
Urology; 2007 May; 69(5):988-95. PubMed ID: 17482957
[TBL] [Abstract][Full Text] [Related]
18. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
[TBL] [Abstract][Full Text] [Related]
19. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on overall and cancer specific survival in men with prostate cancer.
Davies BJ; Smaldone MC; Sadetsky N; Dall'era M; Carroll PR
J Urol; 2009 Jul; 182(1):112-7; discussion 117. PubMed ID: 19447437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
